AS
Ankit Singh
About Ankit Singh
Data last updated:
Ankit Singh has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Omashvani Infrastructure Private Limited and Amenro Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Omashvani Infrastructure Private Limited at ₹9.54 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jul 2019 | 2019 | ₹9.54 Cr (FY 2024) | Active | |
| Director | 06 Dec 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankit Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankit Singh
Ankit Singh has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Omashvani Infrastructure Private Limited and Amenro Healthcare Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Omashvani Infrastructure Private Limited at ₹9.54 Cr (FY 2024).
Ankit Singh is associated with 2 companies as Director, including Omashvani Infrastructure Private Limited (₹9.54 Cr), Amenro Healthcare Private Limited.
Ankit Singh has expertise in General Business, Healthcare.
Ankit Singh has 7 years in corporate governance.
By reported revenue, the largest current company of Ankit Singh is Omashvani Infrastructure Private Limited, with revenue of ₹9.54 Cr (FY 2024).
Ankit Singh currently holds positions at 2 companies: Omashvani Infrastructure Private Limited (₹9.54 Cr), Amenro Healthcare Private Limited.